A detailed history of Black Rock Inc. transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,238,049 shares of MIRM stock, worth $141 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,238,049
Previous 2,452,273 32.04%
Holding current value
$141 Million
Previous $61.6 Million 79.72%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$23.57 - $34.85 $18.5 Million - $27.4 Million
785,776 Added 32.04%
3,238,049 $111 Million
Q1 2024

May 10, 2024

SELL
$24.92 - $30.02 $236,166 - $284,499
-9,477 Reduced 0.38%
2,452,273 $61.6 Million
Q4 2023

Feb 13, 2024

BUY
$27.14 - $34.93 $9.45 Million - $12.2 Million
348,341 Added 16.48%
2,461,750 $72.7 Million
Q3 2023

Nov 13, 2023

BUY
$24.63 - $32.85 $2.05 Million - $2.73 Million
83,034 Added 4.09%
2,113,409 $66.8 Million
Q2 2023

Aug 11, 2023

BUY
$23.51 - $30.09 $7.54 Million - $9.65 Million
320,549 Added 18.75%
2,030,375 $52.5 Million
Q1 2023

May 12, 2023

SELL
$19.19 - $24.1 $8.19 Million - $10.3 Million
-426,851 Reduced 19.98%
1,709,826 $41.1 Million
Q4 2022

Feb 13, 2023

BUY
$17.59 - $23.83 $6.81 Million - $9.23 Million
387,328 Added 22.14%
2,136,677 $41.7 Million
Q3 2022

Nov 14, 2022

BUY
$19.98 - $29.44 $7.06 Million - $10.4 Million
353,337 Added 25.31%
1,749,349 $36.8 Million
Q2 2022

Aug 12, 2022

BUY
$18.42 - $27.5 $11.3 Million - $16.9 Million
613,182 Added 78.33%
1,396,012 $27.2 Million
Q1 2022

May 12, 2022

BUY
$15.5 - $23.93 $166,346 - $256,816
10,732 Added 1.39%
782,830 $17.2 Million
Q4 2021

Feb 10, 2022

BUY
$13.05 - $19.35 $2.11 Million - $3.13 Million
161,533 Added 26.46%
772,098 $12.3 Million
Q3 2021

Nov 09, 2021

BUY
$13.95 - $20.18 $39,492 - $57,129
2,831 Added 0.47%
610,565 $12.2 Million
Q2 2021

Aug 11, 2021

BUY
$15.84 - $20.6 $9.63 Million - $12.5 Million
607,734 New
607,734 $10.5 Million

Others Institutions Holding MIRM

About Mirum Pharmaceuticals, Inc.


  • Ticker MIRM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,751,700
  • Market Cap $1.61B
  • Description
  • Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...
More about MIRM
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.